Whalegun
Home

Jonathan Zalevsky, Chief R&D Officer: Nektar Therapeutics NKTR Sell · Filed 06/17

Trade details

Type
Insider sale
Amount
$336,211.98
Shares · price
5,538 sh · $60.71 a share
Held after
15,437 sh
Stock
Nektar Therapeutics NKTR
Person
Jonathan ZalevskyChief R&D Officer
Trade date
26/06/15
Filed
26/06/17
Days to filing
2 days

Sold 26.4% of holdings

Share of holding sold
26.4%

Nektar Therapeutics trades, last 26 weeks

What else happened in Nektar Therapeutics around then

Filed or reported within 30 days of the trade day · 05/16~07/15

Jonathan Zalevsky's recent trades

  • Jonathan Zalevsky

    Planned saleNektar Therapeutics

    $13.4K

    Filed 08/18

  • Jonathan Zalevsky

    Planned sale10b5-1 planNektar Therapeutics

    $371.5K

    Filed 06/30

  • Jonathan Zalevsky

    Planned sale10b5-1 planNektar Therapeutics

    $328.8K

    Filed 06/15

  • Jonathan Zalevsky

    SellNektar Therapeutics

    $13K

    Filed 05/21

  • Jonathan Zalevsky

    Planned saleNektar Therapeutics

    $13K

    Filed 05/19